Discover and read the best of Twitter Threads about #ASTRO20
Most recents (7)
Here it is: #LateBreakingAbstract at #ASTRO20 SS19 available to view now! Early analysis of trial (NCT03340974) using high-dose SBRT with avasopasem (GC4419) in #PancreaticCancer #PancSM #ASTRO20 Thread👇
This trial tried to address an unmet need for a specific group of #PancreaticCancer #PancSM patients whose disease had not progressed but remained unresectable after chemotherapy. #ASTRO20 @ACKoongMDPhD
Patients would be enrolled on the trial after finishing a minimum of 3 months of standard-of-care chemotherapy. They would receive SBRT with Avasopasem or a placebo control just prior to each SBRT treatment. #ASTRO20 
One day late, but wanted to summarize #PancreaticCancer #PancSM talks from yesterday’s #ASTRO20 session on hypofractionation in GI Cancers before spill the beans on my study... 1/9
Graduating Resident Survey is update & expansion of Practice Entry🌟Response Rate of 94%🌟
98% reported offer for full employment
1% reported entering fellowship
6% non-responders➡️full practice, fellowship, or not employed but🤷they didn't respond.
COVID impacted ~15%
#ASTRO20
98% reported offer for full employment
1% reported entering fellowship
6% non-responders➡️full practice, fellowship, or not employed but🤷they didn't respond.
COVID impacted ~15%
#ASTRO20
Median interviews 5⃣ Median offers 2⃣
Networking is 🗝️ in current job market & @ASTRO_org Career Center also helpful‼️
54% Academics, 30% Private, 13% Hospital Employed Community Practices. #ASTRO20
Networking is 🗝️ in current job market & @ASTRO_org Career Center also helpful‼️
54% Academics, 30% Private, 13% Hospital Employed Community Practices. #ASTRO20
Now let's talk about the 💰
Median *GROUP* for year 1 $300,000-$350,000 and $350,000-$400,000 year 2 (does not rep exact median due to limitations in how data was collected- will be addressed for 2021) #ASTRO20
Median *GROUP* for year 1 $300,000-$350,000 and $350,000-$400,000 year 2 (does not rep exact median due to limitations in how data was collected- will be addressed for 2021) #ASTRO20
Starting off with Radiation Oncology Economics by Amar Rewari, MD in the LIVE ARRO Session. Great info for now and also to reference later! #ASTRO20
Physician Work (small portion), Practice Expense (high/majority), and Liability Insurance make up cost of each code. #ASTRO20
Conversion Factor 2020 36 but will be decreased down to 32 for 2021 to achieve budget neutrality, so care will be reimbursed for less next year.
Starting now: Preserving Radiation Oncology by Investing in Training - panel featuring @emmacfields of @RadOncPDs, @daniel_petereit of @AmericanBrachy, @PottersMD of SCAROP, @NehaVapiwala of @acgme RRC, all moderated by @RTendulkarMD!
First up: the Job Market!
@NehaVapiwala: central regulation from @ASTRO_org and others raises antitrust concerns
@PottersMD: hiring calendar has been pushed back over time, increasing anxiety
@NehaVapiwala: central regulation from @ASTRO_org and others raises antitrust concerns
@PottersMD: hiring calendar has been pushed back over time, increasing anxiety
▶️Effectiveness, Efficiency, Engagement to achieve the next level
▶️Good to Great: importance of building the right team, looking at the facts, building the right culture, humility in leadership
▶️Good to Great: importance of building the right team, looking at the facts, building the right culture, humility in leadership
▶️improvement is an iterative process:
set goals ➡️review performance ➡️execute to close gaps➡️celebrate success➡️set goals
▶️be aware of the difference between managing and leading
set goals ➡️review performance ➡️execute to close gaps➡️celebrate success➡️set goals
▶️be aware of the difference between managing and leading
OK #medtwitter #scitwitter #doubledocs #radonc and #newpi tweeps: I have been charged with discussing "Recruitment and Retention of Physician Scientists" in #radonc at a panel for @ASTRO_org #ASTRO20. What are we doing right? What could we improve?
Lookin' @KimpleRandall @Samuel_Bakhoum @GeneCollector @pipcosper @IBCradiation @NickiSimone4 @decitrin @KevinCamphausen @rweichselbaum @xrtGenomics @DeSelmMD @jeremy_setton @guptalabunc @ranjitbindra @benlok @HimanshuNagarMD @TaniguchiMD
DMs or public tweets welcomed! Would love to get a diverse cache of perspectives! Please spread the word! Apologies in advance if I missed some folks. I'm still getting the hang of this twitter thing.
